In the present study, 998 glioma patients with transcriptome data were enrolled and analyzed, aiming at investigating the clinical significance, characterization of expression profiling, and biological function of BDKRB2 in glioma. This evidence concerns the gene BDKRB2 and central nervous system cancer.